China SXT Pharmaceuticals Files 6-K with Purchase Agreement
Ticker: SXTC · Form: 6-K · Filed: Apr 9, 2026 · CIK: 0001723980
| Field | Detail |
|---|---|
| Company | China Sxt Pharmaceuticals, Inc. (SXTC) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, securities-purchase-agreement, legal-opinion
TL;DR
SXT filed a 6-K on 4/9/26 detailing a securities purchase agreement from 4/7/26.
AI Summary
China SXT Pharmaceuticals, Inc. filed a Form 6-K on April 9, 2026, reporting its status as a foreign issuer. The filing includes a Securities Purchase Agreement dated April 7, 2026, and an opinion from Appleby. The company's mailing and business address are both listed as 178 Taidong Road North, Taizhou, China.
Why It Matters
This filing indicates ongoing corporate activities and potential transactions for China SXT Pharmaceuticals, Inc., which could impact its future operations and investor relations.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign issuer and does not contain significant negative news or financial distress indicators.
Key Players & Entities
- China SXT Pharmaceuticals, Inc. (company) — Filer
- Appleby (company) — Legal counsel providing an opinion
- April 9, 2026 (date) — Filing Date
- April 7, 2026 (date) — Date of Securities Purchase Agreement
FAQ
What is the purpose of the Form 6-K filing by China SXT Pharmaceuticals, Inc.?
The Form 6-K is a report of a foreign issuer, filed on April 9, 2026, to provide updates and relevant documents to the SEC.
What key documents are included in this 6-K filing?
The filing includes the main report, an opinion from Appleby, and a Form of Securities Purchase Agreement dated April 7, 2026.
When was the Securities Purchase Agreement dated?
The Form of Securities Purchase Agreement is dated as of April 7, 2026.
What is the business address of China SXT Pharmaceuticals, Inc.?
The business address is 178 Taidong Road North, Taizhou, China.
What is the CIK number for China SXT Pharmaceuticals, Inc.?
The CIK number for China SXT Pharmaceuticals, Inc. is 0001723980.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2026 regarding China SXT Pharmaceuticals, Inc. (SXTC).